The application was filed in 2006 by Motorola Mobility LLC, now changed to Google Technology Holdings LLC for method and apparatus of providing text messages
The medicines include tuberculosis drug moxifloxacin, antipsychotic olanzapine and valgancicloivir, a medicine often needed for HIV/AIDS patients. The groups allege that none of these drugs qualified the criteria specified under the Indian Patents Act and were given patent protection because the patent examiners overlooked the legal safeguards meant to avoid grant of patents to known substances or their mere improvements.
In less than a year since the first patent electronic application was filed at the Indian Patent Office, the number has increased to 1,000, up three per cent.
'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'
'India is often skipping legacy cycles and moving directly to advanced AI-driven operations.'
Sources said the people would be hired at different levels, including application examiners.
Swiss drug multinational Roche AG suffered yet another setback in its ongoing patent fights in India after the Chennai patent office rejected its claim over Valcyte (valganciclovir).
The Delhi High Court has scheduled a hearing for March 9 on the Enforcement Directorate's plea challenging a trial court order that refused to acknowledge its chargesheet against Congress leaders Sonia and Rahul Gandhi in the National Herald money laundering case.
Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.
'Solutions developed in India are being commercialised and offered globally because we're executing at scale, creating new markets and revenue streams.'
The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.
After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology (biotech) company clarified that in the "rush" to develop vaccines and file appropriate patents, BBIL had missed adding ICMR's name in the original filings.
The US on Tuesday again placed India on its 'priority watch list' stating that New Delhi remains one of the world's most challenging major economies with respect to protection and enforcement of intellectual property (IP) rights.
2025 has seen a sharp rise in lawsuits targeting IT services and consulting companies, which now increasingly offer proprietary digital platforms and cloud services.
India granted 1.03 lakh patents in financial year 2023-24, Controller General of Patents, Designs and Trademarks Unnat Pandit said on Thursday, as he assured that there will be "no delay" in the Intellectual Property Office as it prioritises timely clearance of applications. Addressing an Assocham event here, he shared that 40 per cent of the applications were disposed of within 30 months of the request for examination. "We are going to have no delay in the IP office, that's the motive with which we have .. that IP should be granted and under Chapter 8 of the Act it should also be utilised by the applicant ... that will generate the economic value of IP," Pandit said.
Swiss pharmaceutical major Hoffmann-La Roche's patents rights over Hepatitis C drug Pegasys has been challenged by public interest groups at the Indian Patent Office.
Trump said California has been particularly "hard hit" because of this, blaming democrat Gavin Newsom, the Governor of California, for this loss, calling him "weak and incompetent."
The patent application for 'System and method for wearable electronic devices', filed in 2007, mentions various wearable models including a shoe that can communicate data to the user, electronic communication devices attached to clothes, wireless ear pieces and ankle bracelets that can transmit updated information from the body to the user. The drawings the company submitted to the patent office also show the design of a shoe that can be a wearable electronic device.
In yet another setback to Swiss drug multinational Novartis AG, the Indian patent office has rejected its application to secure a patent for an alfa crystal form of its blockbuster cancer medicine, Glivec.
The contentious issue of software patents is rearing its head again, both in India and globally. The Indian Patent Office, for instance, invited companies and institutions to comment on its Draft Manual 2008 - Patent Practice & Procedure (software patents included) this April.
Data contradict Swiss drug major's claim that India does not respect IPR.
For the first time in India, the facility enables 3D printing of aerospace and rocket components up to one metre in height.
An first information report (FIR) was registered on Tuesday against Bharatiya Janata Party IT cell head Amit Malviya and Editor-in-Chief of Republic TV, Arnab Goswami for allegedly running false information, police said.
Absence of operational manual that guides examiners, heavy backlog take a toll.
Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the country.
TVK cadres are worried, the leadership looks weak, and the party is not fully prepared for the 2026 elections, observes N Sathiya Moorthy.
Individual scientists attached to research institutions and domestic companies like Lupin, Dr Reddy's and Cadila account for the rest.
The Indian Patent Office has granted the company its 'SNS' invention with patent no. 234044 on May 1, 2009, the company said. Bajaj Auto has applied for patent in several countries for this unique technology and is taking necessary steps to counter the menace of Chinese manufacturers unscrupulously marketing cheap copies of the technology in Nigeria (as 'NeXus' brand motorcycle) and in Kenya and Uganda (as 'Nebula' brand motorcycle), the statement added.
India has rejected a drug patent application of a United States multinational pharma company, paving the way for easy access to an important life-saving medication for HIV patients across the globe.
The Prime Minister's Office (PMO) has sought the opinion of various stakeholder departments on the need for further amendments to the patent law to introduce some of the controversial provisions that were kept out during the previous amendment to the Indian Patent Act five years ago.
Hero MotoCorp and TVS Motor crossed Rs 1,000 crore in R&D spend for the first time, as legacy OEMs accelerate innovation to compete with new-age EV players.
Multinational organizations including PepsiCo and industry associations like IPA, have come in favour of India's intellectual property regime, which is being reviewed by the US administration.
Reliance Industries Ltd has withdrawn its trademark application for the term 'Operation Sindoor' -- the codename for India's military strikes in Pakistan -- stating that it was inadvertently filed by a junior employee without authorisation.
'They wanted the city to be a great business hub. They didn't like the fact that taxes collected in Bombay would go outside the city.'
Minister of Science & Technology and Earth Sciences Prithviraj Chavan says in an exclusive interview that India has digitized all traditional knowledge of medicine available in India and has shared it with the US President and United States patents office so that nobody benefits unduly by using Indian knowledge and files for patents on such products.
Patent filings in India would be more and more driven by new technologies, which are either kept secret or patented.
Indian companies need not just make in India, but invent in India too
If the 'Captain Cool' trademark goes through, it could trigger a wave of similar attempts by celebrities to trademark nicknames given to them by fans.
The rules, the first ever for software applications in the country, were recently issued by the patent office and mandate each new software to be 'machine-specific' and packaged with 'new hardware' to qualify for a licence.
'We don't have to compete with Maharashtra or Gujarat. We have to now start thinking about how we compete with the United States or China.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances